Both in Pharmaceuticals
ArriVent BioPharma vs Geron
Over the past year AVBP returned −26.9% and GERN returned −13.8%; their daily moves had a correlation of 0.07.
AVBP −26.9% GERN −13.8%Growth of $1, one year, split-adjusted
| Metric | AVBP | GERN |
|---|---|---|
| Price | $12.87 | $1.04 |
| Market cap | $634.6M | $665.0M |
| Today | −1.15% | +11.29% |
| 1 month | −14.7% | −14.5% |
| 6 months | −56.5% | −34.5% |
| Year to date | −36.0% | −21.6% |
| 1 year | −26.9% | −13.8% |
| Revenue growth (YoY) | — | +17.2% |
| Gross margin | — | 83.9% |
| Net margin | — | −29.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.3× |
| Net cash | $373.1M | $51.1M |
| Dividend yield | — | — |
| Volatility (60d) | 154.3% | 60.7% |
| Short % of float | 20.3% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).